MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01)

Clinical trial NCT04495621 · COMPLETED

Trial details

NCT number: NCT04495621
Sponsor: Menarini Group
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2020-07-20
Primary completion: 2024-01-12
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.